Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
General Motors shares tumbled after the company said its driverless taxi division, Cruise, will suspend production of the Origin robotaxi.
Shell has started to shop around for buyers to offload its stake in an offshore wind project off the coast of Scotland.
Ryanair said it had seen its profits take a 46% nosedive, and would have to offer “materially lower” airfares for the busy summer period.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
Patents like this serve as a reminder that autonomous vehicles look like more than just cars themselves.
Activist investing firm Elliott Management has taken a significant stake in Starbucks, and has already begun pushing for strategic changes.
Just two years after the mega-merger that brought Warner Bros. and Discovery together, it’s discussing dramatic plans to break up.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
Ford will spend $3 billion to expand production of its popular combustion engine large trucks; Volvo reported a record core operating profit.
Paris-based Pernod Ricard announced Wednesday that it’s selling most of its wine portfolio to a consortium of Australian wine investors.
Italy’s antitrust agency has opened an investigation into Dior and Armani over allegations of worker exploitation.
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.